Especially, CSF CXCL13 levels were found to be increased in neuromyelitis optica (NMO) compared with MS patients and were related to the NMO disease activity indicated by relapse rate and Expanded Disability Status Scale (EDSS) scores [60]. This evidence concerns the gene CXCL13 and neuromyelitis optica.